Atlas Trials

Tirbanubulin (Klisiry®) in the Treatment of Basal Cell Carcinoma

Clinical trial NCT06112522 · RECRUITING

Trial details

NCT number
NCT06112522
Sponsor
Centre Hospitalier Universitaire de Nice
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Cell Carcinoma
Start date
2024-02-16
Primary completion
2027-12-16
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.